24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]

75 MG · Extended Release Oral Tablet · oral

A form of apremilast →

24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla] — Selective immunosuppressants. Strength, form, class, interactions & more.

24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]

Active ingredient

Classification

Selective immunosuppressantsPhosphodiesterase 4 Inhibitor

Drug interactions

Apremilast may have reduced efficacy when co-administered with strong CYP450 inducers.

  • moderatestrong CYP450 inducers (such as rifampin) — decreases apremilast exposure and may result in loss of efficacy

Real-world adverse events (FAERS)

Diarrhoea24,445Nausea22,018Psoriasis20,366Headache17,784Drug Ineffective15,439Abdominal Discomfort8,145Psoriatic Arthropathy7,958Pain6,733

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.